News
Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...
In today’s digital systems, vast volumes of information are produced daily. However, simply collecting large amounts of data is not enough. That data must be reliable and well-structured to serve any ...
4d
News-Medical.Net on MSNStudy validates stem cell models for neurological diseasesIn a comprehensive Genomic Press perspective (peer-reviewed review) article, an international team of neuroscientists has ...
High-throughput synapse profiling reveals cell-type-specific spatial configurations in the fly brain
Characterization of intracellular synapse heterogeneity aides to understand the intricate computational logic of neuronal circuits. Despite recent advances in connectomics, the spatial patterns of ...
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...
3d
News Medical on MSNAI-based tool can ‘measure’ cancer aggressiveness and paves the way for new therapiesDeveloped at the University of São Paulo, the model uses protein expression to create a stemness index that analyzes the similarity of tumors to pluripotent stem cells. The article was published in ...
The burden then shifts to hospitals, which puts clinicians in a tough spot, relying on AI that might not generalize, with no ...
Battery X Metals Inc.'s wholly-owned subsidiary, Battery X Rebalancing Technologies Inc., has entered into a Commercial Revenue Share Agreement with an arm's length, independent ...
Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results